Why the study?
Circulating biomarkers and imaging techniques provide independent and complementary information to guide heart failure management, warranting evidence-based indications for their clinical integration.
This ESC/HFA consensus document provides clinical recommendations for integrating imaging and circulating biomarkers to guide heart failure management.
Answers are grounded in this paper and cite their sources.
Guides integration of biomarkers with imaging in HF management; extends prior consensus with updated evidence synthesis.
Circulating biomarkers and imaging techniques provide independent and complementary information to guide management of heart failure (HF). This consensus document by the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) presents current evidence-based indications relevant to integration of imaging techniques and biomarkers in HF. The document first focuses on application of circulating biomarkers together with imaging findings, in the broad domains of screening, diagnosis, risk stratification, guidance of treatment and monitoring, and then discusses specific challenging settings. In each section we crystallize clinically relevant recommendations and identify directions for future research. The target readership of this document includes cardiologists, internal medicine specialists and other clinicians dealing with HF patients.
No takes yet. Share an insight, caveat, or question.
Moura et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: